In the BioHarmony Drug Report Database

"Preview" Icon

Lithium carbonate

Eskalith, Lithane, Lithium Carbonate, Lithobid, Lithonate, Lithotabs (lithium carbonate) is a small molecule pharmaceutical. Lithium carbonate was first approved as Eskalith on 1982-01-01. It is used to treat bipolar disorder, conduct disorder, depressive disorder, and post-traumatic stress disorders in the USA. The pharmaceutical is active against inositol monophosphatase 1. In addition, it is known to target glycogen synthase kinase-3 beta.

 

Trade Name

 

Eskalith, Lithane, Lithium Carbonate, Lithobid, Lithonate, Lithotabs
 

Common Name

 

lithium carbonate
 

ChEMBL ID

 

CHEMBL1200826
 

Indication

 

bipolar disorder, conduct disorder, depressive disorder, post-traumatic stress disorders
 

Drug Class

 

Image (chem structure or protein)

Lithium carbonate structure rendering